Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program

OBJECTIVE: The objective was to determine the safety of ocrelizumab (OCR) in patients with rheumatoid arthritis (RA). METHODS: This was an analysis of the double-blind, placebo-controlled periods and long-term follow-up of 4 OCR phase III trials in RA (SCRIPT, STAGE, FILM and FEATURE). Safety data p...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Rigby, William, Tak, Paul P., Dörner, Thomas, Olech, Ewa, Martin, Carmen, Millar, Laurie, Travers, Helen, Fisheleva, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911947/
https://www.ncbi.nlm.nih.gov/pubmed/24498318
http://dx.doi.org/10.1371/journal.pone.0087379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911947/
https://www.ncbi.nlm.nih.gov/pubmed/24498318
http://dx.doi.org/10.1371/journal.pone.0087379

Ejemplares similares